Found 52 matching trials
Histopathological Response to FOLFOXIRI + Bevacizumab in Peritoneal Metastasis From Colorectal Cancer PHASE2 There is a paucity of data on the histopathological response of peritoneal ...
Show More Location
Medical University of Vienna, Department of Internal Medicine I
Learn More & Join Trial
Curative Resectability of Not Optimally Resectable Liver and/or Lung Metastases From Colorectal Carcinoma (CRC) Under Intensified Chemotherapy PHASE2 The purpose of this clinical trial is to primarily assess the efficacy of a...
Show More Learn More & Join Trial
Regorafenib as Single Agent in Patients With Metastatic Colorectal Cancer (mCRC) With Any RAS or BRAF Mutation Previously Treated With FOLFOXIRI Plus Bevacizumab PHASE2 The purpose of this study is to assess the efficacy of single-agent regoraf...
Show More Location
Spanish Cooperative Group for Digestive Tumour Therapy (TTD)
Learn More & Join Trial
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial PHASE3 This phase III trial compares hepatic arterial infusion (HAI) (pump chemoth...
Show More Location
University of Alabama at Birmingham Cancer Center
Learn More & Join Trial
A Multicenter, Clinical Study of FOLFOXIRI With Bevacizumab As First-line Therapy in Patients With mCRC PHASE2 The purpose of this study to assess efficacy and tolerability of combinatio...
Show More Learn More & Join Trial
Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving FOLFOXIRI/Bevacizumab for Metastatic Colorectal Cancer (mCRC): PHASE3 This was a randomized, double-blind, placebo-controlled, global, multicente...
Show More Location
AZ Oncology Associates - HOPE
Learn More & Join Trial
Induction Chemoterapy With Folfoxiri Plus Cetuxumab in Unresectable Colorectal Cancer Patient PHASE2 This is a phase II randomized study of 4-months induction first-line chemot...
Show More Location
A.O.Universitaria Policlinico S.Orsola-Malpighi Di Bologna (Oncologia Medica)
Learn More & Join Trial
Bevacizumab And Combination Chemotherapy in Rectal Cancer Until Surgery PHASE2 The purpose of this study is to evaluate the efficacy, toxicity and feasibi...
Show More Location
Blackpool Victoria Hospital
Learn More & Join Trial
Ablation With Systemic Therapy vs Liver Resection With Systemic Therapy for Colorectal Liver Metastasis N/A For patients with colorectal liver metastases (CRLM) ≤5 cm, Clinical guidel...
Show More Location
The First Hospital of Jilin University
Learn More & Join Trial
Maintenance Bevacizumab Only or Bevacizumab Plus Metronomic Chemotherapy in Advanced Colorectal Cancer PHASE2 This study consist of 4-months induction first-line chemotherapy with the G...
Show More Location
Istituto Ospedaliero Fondazione Poliambulanza Di Brescia
Learn More & Join Trial